Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for type 2 diabetes, has emerged as one of the most effective weight loss medications available. The medication works by slowing stomach emptying and signaling fullness to your brain, helping reduce hunger and calorie intake. Understanding how dosing progression works can help you know what to expect during your treatment journey with PlexusDx.
How Semaglutide Dosing for Weight Loss Begins
Semaglutide treatment for weight loss starts with a low initial dose to allow your body to adjust and identify the right therapeutic level for you. The first dose is typically 0.25 mg injected once weekly under the skin, a conservative starting point chosen to minimize nausea and other gastrointestinal side effects. This introductory phase usually lasts one to two weeks before your dose advances, giving your system time to acclimate to the medication's effects on appetite and blood sugar regulation.
The rationale behind starting low is backed by clinical experience: most people tolerate the medication better when introduced gradually rather than at higher doses immediately. This approach also helps your healthcare provider identify how your individual body responds to GLP-1 activation, which varies based on factors like your metabolism, existing health conditions, and genetic predispositions. PlexusDx supports this gradual approach with personalized guidance aligned with your treatment goals.
The Typical Semaglutide Dose Escalation Schedule
Most people follow a 16 to 20-week dose escalation schedule, increasing by 0.25 mg each week until reaching their maintenance dose. A standard progression looks like this: 0.25 mg in week one, 0.5 mg in week two, 0.75 mg in week three, and 1.0 mg in week four, with some people continuing to 1.7 mg or 2.4 mg depending on their individual response and treatment targets. The maintenance dose—the amount you'll continue using long-term—is often 1.0 mg or 2.4 mg weekly, though some individuals find lower doses effective and sustainable.
The step-wise progression exists because higher doses produce stronger appetite suppression and metabolic effects, but also increase the likelihood of side effects like nausea or gastrointestinal discomfort. By spacing out increases over weeks, your body gradually adapts to higher GLP-1 receptor signaling, making side effects more manageable and allowing you to distinguish between normal adjustment and problematic reactions. Your PlexusDx provider will monitor your tolerance and results throughout this schedule, adjusting timing if needed based on your unique physiology.
Maintenance Doses and Individualized Semaglutide Treatment
Once you reach your target maintenance dose, you'll continue that dose weekly for the duration of your treatment—there's no further increase unless clinical reasons warrant adjustment. Many patients achieve significant weight loss results at 1.0 mg per week, meaning not everyone needs to climb to the highest available doses. Research shows that weight loss response plateaus at different doses for different people; some individuals see maximal benefit at 0.5 mg or 1.0 mg, while others respond best at higher doses, and genetic factors influence this individual variation.
PlexusDx's Precision Peptide Genetic Test evaluates your genetic predispositions across 14 metabolic pathways, including GLP1R and other peptide-related variants, helping inform whether you may naturally respond better to standard or higher doses. The key principle is that your dose may need to go up, but your PlexusDx price won't—pricing stays flat whether you're at 0.25 mg or 2.4 mg, removing financial barriers to finding your optimal therapeutic level.
Why Semaglutide Dosing Varies Between Individuals
Not everyone needs the same semaglutide dose because weight loss response depends on your individual metabolism, baseline health status, genetics, and how your GLP-1 receptors respond to stimulation. Some people achieve excellent weight loss at 1.0 mg per week and experience diminishing returns at higher doses, while others need 1.7 mg or 2.4 mg to reach their target results. Age, concurrent medications, insulin sensitivity, and even your microbiome composition can influence how effectively semaglutide works and which dose level optimizes your outcomes.
This is why personalized medicine matters: a one-size-fits-all approach to semaglutide dosing ignores the biological reality that your genetics and physiology are unique. The FTO rs9939609 variant and GLP1R rs6923761, both analyzed in PlexusDx's genetic test, are associated with differences in appetite regulation and GLP-1 pathway sensitivity, meaning your genetic profile can help predict whether you're likely to need lower or higher doses. Rather than guessing, PlexusDx integrates genetic insights with clinical assessment to guide dose selection and progression that aligns with your biology.
Semaglutide Pricing at PlexusDx: Dose Increases Don't Cost More
PlexusDx compounded semaglutide injections start at $149 per month across all three commitment tiers, with pricing that remains flat regardless of whether your dose increases over time. This pricing structure removes the common financial stress many patients face when their doctor increases their dose—your monthly investment in treatment stays predictable and transparent. PlexusDx medication comes from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality, and is available to all 50 states without requiring insurance or membership fees.
Because your dose may increase but your price won't, PlexusDx patients can focus entirely on finding their optimal therapeutic dose without worrying about escalating costs. The medication qualifies for HSA and FSA accounts, adding another layer of affordability for eligible patients. If you choose PlexusDx's Precision Peptide Genetic Test ($99 after your first month), you'll gain personalized insights into your peptide pathways that may help your provider make smarter dose recommendations from the start, potentially reducing the trial-and-error typically involved in finding your maintenance dose.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide for weight loss?
The typical starting dose is 0.25 mg injected once weekly, chosen to minimize initial side effects and allow your body to adapt. This low starting point is standard across weight loss protocols and reflects how GLP-1 medications are safest and most tolerable when introduced gradually. PlexusDx providers follow evidence-based dosing guidelines tailored to your health profile.
How long does it take to reach the maintenance dose of semaglutide?
Most patients reach their maintenance dose over 16 to 20 weeks, increasing by 0.25 mg each week until arriving at a therapeutic level between 1.0 and 2.4 mg weekly. This gradual escalation is based on clinical trials showing that slower progression improves tolerability and allows identification of your optimal dose. Some individuals plateau at lower doses with excellent results, while others require higher doses for maximal weight loss.
Does PlexusDx charge more if my semaglutide dose increases?
No. PlexusDx semaglutide injections start at $149 per month with flat pricing across all commitment tiers, meaning your monthly cost stays the same whether you're taking 0.25 mg or 2.4 mg weekly. This transparent pricing model ensures cost never becomes a barrier to reaching your therapeutic dose, and the medication works across all 50 states without insurance requirements.
What are common side effects of semaglutide at different doses?
Lower starting doses (0.25–0.5 mg) often cause mild nausea or appetite changes that typically resolve within days to weeks. At higher maintenance doses (1.0–2.4 mg), some patients experience mild gastrointestinal effects like occasional nausea or loose stools, though many experience none. Side effects are usually temporary and decrease with time; dose escalation allows your body to adjust gradually, minimizing severe reactions.
How can PlexusDx genetic testing help with semaglutide dosing?
PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 150+ genetic insights, including variants in GLP1R and GIPR genes that influence how your body responds to GLP-1 receptor activation. Understanding your genetic predispositions ($99 add-on after your first month) helps your provider predict whether you're likely to respond optimally at standard or higher doses, enabling smarter dose planning from the beginning of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic Only a Shot? Exploring Oral and Injectable Options
Using Ozempic for Effective Weight Loss Strategies